Medical Cannabis Related News
CBD and Cannabinoid Industry Association: education and regulation
CBD and Cannabinoid Industry Association founder Celeste Miranda highlights the importance of education and regulatory oversight.
As the leading trade body for the US CBD...
ICBC founder Alex Rogers talks cannabis access, activism and legislation
Medical Cannabis Network was proud to act as a media partner to the International Cannabis Business Conference (ICBC), one of the world’s largest cannabis...
ICBC San Francisco: Alan Brochstein on cannabis investment
420 Investor and New Cannabis Ventures founder Alan Brochstein spoke to MCN about cannabis investment and regulation.
At the International Cannabis Business Conference (ICBC) in...
Colombian Association of Cannabis Industries: looking to Latin America
In this article the Colombian Association of Cannabis Industries explores the medical cannabis market in Latin America.
As EU demand for cannabis products grows, investors...
Australian Lawyers Alliance: drug policy reform in Australia
Greg Barns, National Criminal Justice Spokesperson for the Australian Lawyers Alliance, calls for evidence-led cannabis policy reform.
One of the most depressing aspects of the...
Research and regulation in Canada with the CCIC
Canadian Consortium for the Investigation of Cannabinoids (CCIC) Deputy Director Dr Lynda Balneaves speaks to MCN about education, research and patient safety.
The Canadian Consortium...
Cannabis, neuropsychiatry and education with Dr Ilya Reznik
Dr Ilya Reznik discusses the use of cannabinoid-based medicines for neuropsychiatric disorders and the barriers to prescribing CBD.
Dr Ilya Reznik has published many original...
Tried and tested high quality CBD products, brought to you by Handpicked CBD
Handpicked CBD is the UK’s choice online retail destination for buying tried and tested, high quality CBD products.
The Handpicked CBD team is on a...
Legislation and regulation in US cannabis
US Cannabis CEO Michael Patterson discusses federal and state cannabis laws and future policy developments.
Michael Patterson is the CEO and founder of US Cannabis...
Liquid Health Labs and PowerCap® provide solutions for cannabis dosing
Dosing is the cannabis industry’s biggest problem. Amid the boom in legalised cannabis and associated products, dosing is proving to be the biggest challenge...
Wholly Hemp: putting phytocannabinoids in focus
Wholly Hemp INC/Cannabidiol Life Brands, showcases the history and future of phytocannabinoid research in the USA and worldwide.
In this article Jessica Arent, Chief Compliance...
Regulation and reputation with Medicinal Cannabis Industry Australia
Rosemary Richards of Medicinal Cannabis Industry Australia tells MCN about industry regulation, licensing and the future of Australian cannabis.
Medicinal Cannabis Industry Australia (MCIA), the...
Medical Cannabis Network Quarterly Issue 2
Medical Cannabis Network Quarterly editor Rosemary Lobley introduces our second edition, which looks at cannabis research, policy and innovation around the world.
Welcome to the...
New study to look at impact of COVID-19 on cannabis patients
A new study will be looking at the impact of the novel coronavirus – COVID-19 – on patients who use medical cannabis.
A preliminary study...
urban-gro: cannabis cultivation space programming
urban-gro, Inc’s team of expert engineers and designers have developed an innovative process for cultivation space design.
In this article, urban-gro, Inc explains more about...
Bryan, Garnier & Co investing in cannabis: driving growth in Europe
Medical Cannabis Network speaks to Dominic Wilson at Bryan, Garnier & Co, Europe’s leading investment bank for fast-growth health and technology companies, about the...
Adivina and tissue culture: the power of predictability
Adivina is dedicated to bringing the proven cultivation benefits of tissue culture propagation to both the cannabis and hemp industries.
Adivina Biosciences was founded by...
New Zealand’s Medical Cannabis Scheme now launched
New Zealand has now launched its Medical Cannabis Scheme that will help patients gain better access to cannabis medicines.
As of April 1, 2020, New...
Exploring cannabinoid bioavailability in the medical cannabis industry
When medication is consumed it must reach the intended site of action, but what is the degree and rate at which it is absorbed...
CBD at the crossroads: a response to the FSA guidelines
Professor Mike Barnes, co-founder of Maple Tree Consultants, responds to the FSA's guidelines regarding CBD products.
As the cannabis market has grown exponentially over the...